Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies

Prevention and treatment of autoimmune disease with luminally administered polyclonal antibodies

US Patent 6346247 · Granted Feb 12, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2024
Generation of therapeutic cells using extracellular components of target organs2023
Macrophage cell therapy to treat orthopedic injury2023
LPS priming of stromal cells to generate LPS-specific exosome educated macrophag2022
Substituted benzo[f]imidazo[1,5-a][1,4]diazepines as GABA(a) receptor modulators2022
GABAA agonists and methods of using to control airway hyperresponsiveness and in2018
Compositions and methods for protecting cells during cancer chemotherapy and rad2017
Therapeutic ribonucleases2017
Methods and compositions for the treatment of cancer2015
Therapeutic ribonucleases2015
Modified ribonucleases2014
Compositions and methods for ribonuclease-based therapeutics2014